help button home button Am J Pathol ASIP 2008 Summer Academy, Molecular Methcanisms of Human Disease: Injury, Inflammation, and Tissue Repair
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shinohara, Y.
Right arrow Articles by Frith, C. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shinohara, Y.
Right arrow Articles by Frith, C. H.

American Journal of Pathology, Vol 100, 455-468, Copyright © 1980 by American Society for Investigative Pathology


REGULAR ARTICLES

Morphologic characteristics of benign and malignant renal cell tumors in control and 2-acetylaminofluorene-treated BALB/c female mice

Y Shinohara and CH Frith

A total of 108 mice with renal cell tumors were obtained from a total of 25,916 control and 2-AAF-treated BALB/c female mice. A total of 119 renal cell adenomas and 37 renal cell carcinomas from the 108 mice were classified morphologically. The 119 renal cell adenomas were divided into cystic (32%), cystopapillary (29%), papillary (24%), and solid (15%). The 37 renal cell carcinomas were divided into tubolosolid (16%), tubolopapillary (49%) and tubulopleomorphic (35%). Pulmonary metastases occurred only in the tubulopleomorphic adenocarcinomas. In mice having renal cell tumors and surviving less than 650 days, the renal cell carcinomas were usually multiple and renal cell adenomas often coexisted in the same kidney. In mice having renal cell tumors and surviving more than 650 days, the renal cell carcinomas usually consisted of single large tumors without coexisting renal cell adenomas. The results suggest that the renal cell adenoma may progress to renal cell carcinoma. The various dose levels of 2-AAF did not significantly affect the incidence of renal cell tumors.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1980 by the American Society for Investigative Pathology.